{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:28:42Z","timestamp":1785774522452,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00198-020-05653-0","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:03:06Z","timestamp":1603897386000},"page":"663-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5228-5755","authenticated-orcid":false,"given":"F.-P.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-S.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-J.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"5653_CR1","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"5653_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers MJ, Crockett JC, Coxon FP, Monkkonen J (2011) Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49:34\u201341","journal-title":"Bone"},{"key":"5653_CR3","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95:4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"key":"5653_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jbmr.5650100617","volume":"10","author":"DH Schweitzer","year":"1995","unstructured":"Schweitzer DH, Oostendorp-van de Ruit M, Van der Pluijm G, L\u00f6wik CW, Papapoulos SE (1995) Interleukin-6 and the acute phase response during treatment of patients with Paget\u2019s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxyl-propylidene bisphosphonate. J Bone Miner Res 10:956\u2013962","journal-title":"J Bone Miner Res"},{"key":"5653_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s002239900353","volume":"61","author":"D Thiebaud","year":"1997","unstructured":"Thiebaud D, Sauty A, Burckhardt P et al (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61:386\u2013392","journal-title":"Calcif Tissue Int"},{"key":"5653_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/107999003322558782","volume":"23","author":"G Dicuonzo","year":"2003","unstructured":"Dicuonzo G, Vincenzi B, Santini D, Avvisati G, Rocci L, Battistoni F, Gavasci M, Borzomati D, Coppola R, Tonini G (2003) Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6. J Interf Cytokine Res 23:649\u2013654","journal-title":"J Interf Cytokine Res"},{"key":"5653_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.leu.2403693","volume":"19","author":"S Mariani","year":"2005","unstructured":"Mariani S, Muraro M, Pantaleoni F, Fiore F, Nuschak B, Peola S, Foglietta M, Palumbo A, Coscia M, Castella B, Bruno B, Bertieri R, Boano L, Boccadoro M, Massaia M (2005) Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia 19:664\u2013670","journal-title":"Leukemia"},{"key":"5653_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00198-011-1563-8","volume":"23","author":"JD Wark","year":"2012","unstructured":"Wark JD, Bensen W, Recknor C, Ryabitseva O, Chiodo J III, Mesenbrink P, de Villiers TJ (2012) Treatment with acetaminophen\/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg. Osteoporos Int 23:503\u2013512","journal-title":"Osteoporos Int"},{"key":"5653_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1359\/jbmr.081016","volume":"24","author":"T Srivastava","year":"2009","unstructured":"Srivastava T, Haney CJ, Alon US (2009) Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. J Bone Miner Res 24:334\u2013337","journal-title":"J Bone Miner Res"},{"key":"5653_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/ard.2008.098335","volume":"68","author":"DY Chen","year":"2009","unstructured":"Chen DY, Chen YM, Ho WL, Chen HH, Shen GH, Lan JL (2009) Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still\u2019s disease. Ann Rheum Dis 68:1074\u20131075","journal-title":"Ann Rheum Dis"},{"key":"5653_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1365-3083.1995.tb03599.x","volume":"41","author":"F Spinozzi","year":"1995","unstructured":"Spinozzi F, Agea E, Bistoni O et al (1995) T lymphocytes bearing the gamma delta T cell receptor are susceptible to steroid-induced programmed cell death. Scand J Immunol 41:504\u2013508","journal-title":"Scand J Immunol"},{"key":"5653_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1385\/JCD:7:1:7","volume":"7","author":"Writing Group for the ISCD Position Development Conference","year":"2004","unstructured":"Writing Group for the ISCD Position Development Conference (2004) Position statement: executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference. J Clin Densitom 7:7\u201312","journal-title":"J Clin Densitom"},{"key":"5653_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00774-010-0223-y","volume":"29","author":"JS Hwang","year":"2011","unstructured":"Hwang JS, Chin LS, Chen JF, Yang TS, Chen PQ, Tsai KS, Leung PC (2011) The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis. J Bone Miner Metab 29:328\u2013333","journal-title":"J Bone Miner Metab"},{"key":"5653_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/os.12338","volume":"9","author":"Y Ding","year":"2017","unstructured":"Ding Y, Zeng JC, Yin F, Zhang CL, Zhang Y, Li SX, Liu X, Zhang C, Xue QY, Lin H, Pei FX (2017) Multicenter study on observation of acute-phase responses after infusion of zoledronic acid 5\u2009mg in Chinese women with postmenopausal osteoporosis. Orthop Surg 9:284\u2013289","journal-title":"Orthop Surg"},{"key":"5653_CR15","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00198-010-1448-2","volume":"22","author":"SL Silverman","year":"2011","unstructured":"Silverman SL, Kriegman A, Goncalves J, Kianifard F, Carlson T, Leary E (2011) Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid. Osteoporos Int 22:2337\u20132345","journal-title":"Osteoporos Int"},{"key":"5653_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jbmr.1797","volume":"28","author":"JL Welton","year":"2013","unstructured":"Welton JL, Morgan MP, Mart\u00ed S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M (2013) Monocytes and \u03b3\u03b4 T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res 28:464\u2013471","journal-title":"J Bone Miner Res"},{"key":"5653_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/08923973.2013.764504","volume":"35","author":"T Ma\u015blanka","year":"2013","unstructured":"Ma\u015blanka T (2013) Dexamethasone inhibits and meloxicam promotes proliferation of bovine NK cells. Immunopharmacol Immunotoxicol 35:225\u2013234","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5653_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00198-017-3960-0","volume":"28","author":"EO Billington","year":"2017","unstructured":"Billington EO, Horne A, Gamble GD, Maslowski K, House M, Reid IR (2017) Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial. Osteoporos Int 28:1867\u20131874","journal-title":"Osteoporos Int"},{"key":"5653_CR19","unstructured":"Johnson DB, Kelley B (Updated 2019 Oct 2) Dexamethasone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482130\/. Accessed 26 January, 2020"},{"key":"5653_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/ard.2008.092163","volume":"68","author":"D Huscher","year":"2009","unstructured":"Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68:1119\u20131124","journal-title":"Ann Rheum Dis"},{"key":"5653_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4158\/EP161638.OR","volume":"24","author":"C Crotti","year":"2018","unstructured":"Crotti C, Watts NB, De Santis M et al (2018) Acute phase reactions after zoledronic acid infusion: protective role of 25-hydroxyvitamin D and previous oral bisphosphonate therapy. Endocr Pract 24:405\u2013410","journal-title":"Endocr Pract"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-020-05653-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T16:12:54Z","timestamp":1617811974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-020-05653-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5653"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05653-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Chang Gung Medical Foundation (IRB: 201600772B0 and IRB: 201800841B0).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}